A novel approach to the treatment of ulcerative colitis: Is it kosher?

Gastroenterology

Volumn 128, Issue 4, 2005, Pages 1117-1119

  Mayer, Lloyd ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON ANTIBODY; IMMUNOSTIMULATING AGENT; INTERLEUKIN 12 ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CLINICAL TRIAL; CROHN DISEASE; EDITORIAL; GENETIC PREDISPOSITION; HELMINTHIASIS; HEREDITY; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TRICHURIS; TRICHURIS SUIS; ULCERATIVE COLITIS;

EID: 17144399155     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.02.038     Document Type: Editorial

References (18)

1. W.J. Sandborn, S.R. Targan Biologic therapy of inflammatory bowel disease Gastroenterology 122 2002 1592 1608
2. R.B. Sartor Review article How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment Pharmacol Ther 11 Suppl 3 1997 89 96 ; discussion 96-97
3. K. Matsuoka, N. Inoue, T. Sato, S. Okamoto, T. Hisamatsu, Y. Kishi, A. Sakuraba, O. Hitotsumatsu, H. Ogata, K. Koganei, T. Fukushima, T. Kanai, M. Watanabe, H. Ishii, T. Hibi T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease Gut 53 2004 1303 1308
4. G.E. Mullin, A.J. Lazenby, M.L. Harris, T.M. Bayless, S.P. James Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis Gastroenterology 102 1992 1620 1627
5. R.P. MacDermott, G.S. Nash, M.G. Scott, M.H. Nahm, M.J. Bertovich, I.J. Kodner Altered patterns of secretion of IgA and IgG subclasses by ulcerative colitis and Crohn's disease intestinal mononuclear cells Adv Exp Med Biol 216A 1987 335 344
6. P.J. Mannon, I.J. Fuss, L. Mayer, C.O. Elson, W.J. Sandborn, D. Present, B. Dolin, N. Goodman, C. Groden, R.L. Hornung, M. Quezado, M.F. Neurath, J. Salfeld, G.M. Veldman, U. Schwertschlag, W. Strober Anti-IL-12 Crohn's Disease Study Group Anti-interleukin-12 antibody for active Crohn's disease N Engl J Med 351 2004 2069 2079
7. S.R. Targan, S.B. Hanauer, S.J. van Deventer, L. Mayer, D.H. Present, T. Braakman, K.L. DeWoody, T.F. Schaible, P.J. Rutgeerts A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group N Engl J Med 337 1997 1029 1035
8. W.J. Sandborn How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease Rev Gastroenterol Disord 4 Suppl 3 2004 S25 S33
9. I.J. Fuss, F. Heller, M. Boirivant, F. Leon, M. Yoshida, S. Fichtner-Feigl, Z. Yang, M. Exley, A. Kitani, R.S. Blumberg, P. Mannon, W. Strober Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis J Clin Invest 113 2004 1490 1497
10. P. Salomon, A. Pizzimenti, A. Panja, A. Reisman, L. Mayer The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium Autoimmunity 9 1991 141 149
11. S. Romagnani Immunologic influences on allergy and the TH1/TH2 balance J Allergy Clin Immunol 113 2004 395 400
12. A. Capron, D. Dombrowicz, M. Capron Helminth infections and allergic diseases from the th2 paradigm to regulatory networks Clin Rev Allergy Immunol 26 2004 25 34
13. M. Wills-Karp, J. Santeliz, C.L. Karp The germless theory of allergic disease revisiting the hygiene hypothesis Nat Rev Immunol 1 2001 69 75
14. M. Yazdanbakhsh, P.G. Kremsner, R. van Ree Allergy, parasites, and the hygiene hypothesis Science 296 2002 490 494
15. R.W. Summers, D.E. Elliott, J.F. Urban Jr, R.A. Thompson, J.V. Weinstock Trichuris suis therapy for active ulcerative colitis a randomized controlled trial Gastroenterology 128 2005 825 832
16. D.E. Elliott, J. Li, A. Blum, A. Metwali, K. Qadir, J.F. Urban Jr, J.V. Weinstock Exposure to schistosome eggs protects mice from TNBS-induced colitis Am J Physiol Gastrointest Liver Physiol 284 2003 G385 G391
17. R.S. Walmsley, R.C. Ayres, R.E. Pounder, R.N. Allan A simple clinical colitis activity index Gut 43 1998 29 32
18. L. Cervi, A.S. MacDonald, C. Kane, F. Dzierszinski, E.J. Pearce Cutting edge dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses J Immunol 172 2004 2016 2020